Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies

Hepatocellular carcinoma (HCC) is the most common liver cancer with high morbidity and mortality worldwide. Systemic treatments with several multi-targeted tyrosine kinase inhibitors (TKIs), including sorafenib, lenvatinib, regorafenib and cabozantinib, have been widely utilized int the treatment of...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Am J Cancer Res
मुख्य लेखकों: Cheng, Huijuan, Sun, Guodong, Chen, Hao, Li, Yu, Han, Zhijian, Li, Yangbing, Zhang, Peng, Yang, Luxi, Li, Yumin
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: e-Century Publishing Corporation 2019
विषय:
Review Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6726979/
https://ncbi.nlm.nih.gov/pubmed/31497341
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन